Name | Rifaximin |
---|---|
Supplier | Tocris Bioscience |
Catalog | 4121 |
Prices | $49.00 |
Sizes | 50 mg |
Function Type | Agonist |
Cas Number | 80621-81-4 |
Chemical Name | (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-25-(Acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione |
Formula | C43H51N3O11 |
Molecular Weight | 785.88 |
Purity | >98 % |
Description | Pregnane X receptor (PXR) agonist; antibiotic. Reduces number of colon tumors and suppresses expression of TNF α and Il-1 β induced in a colon cancer, PXR-humanized mouse model. Increases apoptosis and decreased proliferation in HT-29 cells. Exhibits low gastrointestinal absorption while retaining its antibacterial activity. Active against gram-positive and gram-negative bacteria. |
Supplier Page | Shop |
Jiang ZD, DuPont HL. Chemotherapy. 2005;51 Suppl 1:67-72.
Stradi R, Nava D, Nebuloni M, Pastura B, Pini E. J Pharm Biomed Anal. 2010 Mar 11;51(4):858-65.
Cheng J, Fang ZZ, Nagaoka K, Okamoto M, Qu A, Tanaka N, Kimura S, Gonzalez FJ. J Pharmacol Exp Ther. 2014 Dec;351(3):559-67.